Contract manufacturing, royalty and other revenue — Revenue
Biogen Contract manufacturing, royalty and other revenue — Revenue remained flat by 0.0% to $183.23M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.3%, from $163.15M to $183.23M. Over 4 years (FY 2021 to FY 2025), Contract manufacturing, royalty and other revenue — Revenue shows an upward trend with a 11.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Growth in this metric indicates expanding partnership influence or increased utilization of manufacturing assets by external clients, whereas a decline could signal the sunsetting of royalty-bearing products or loss of manufacturing contracts.
Detailed definition
This metric tracks the specific revenue recognized from contract manufacturing arrangements and royalty payments derived...
Peer comparison
Comparable to 'Royalty and Contract Revenue' lines found in other large-cap biotech firms that utilize out-licensing models or provide manufacturing support to smaller biotech partners.
biib_segment_contract_manufacturing_royalty_and_other_revenue_revenueHistorical Data
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $476.30M | $485.10M | $899.30M | $652.60M | $732.90M |
| YoY Change | — | +1.8% | +85.4% | -27.4% | +12.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's contract manufacturing, royalty and other revenue — revenue?
- Biogen (BIIB) reported contract manufacturing, royalty and other revenue — revenue of $183.23M in Q4 2025.
- How has Biogen's contract manufacturing, royalty and other revenue — revenue changed year-over-year?
- Biogen's contract manufacturing, royalty and other revenue — revenue increased by 12.3% year-over-year, from $163.15M to $183.23M.
- What is the long-term trend for Biogen's contract manufacturing, royalty and other revenue — revenue?
- Over 4 years (2021 to 2025), Biogen's contract manufacturing, royalty and other revenue — revenue has grown at a 11.4% compound annual growth rate (CAGR), from $476.30M to $732.90M.
- What does contract manufacturing, royalty and other revenue — revenue mean?
- Revenue specifically derived from contract manufacturing services and royalty payments received from third parties.